Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Viralytics closes $A27mm private placement

Executive Summary

Viralytics Ltd. (cancer immunotherapies) raised $A27mm ($24mm) through a private placement to twelve new US- and UK-based institutional health care investors. The company sold 97mm shares at $A0.28 (a 7% discount to the market average before the two-tranche placement was initially launched in January). Roth Capital was the placement agent.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Biotech
    • Private Placement

Related Companies